News
23h
News-Medical.Net on MSNAI-designed drug shows early promise for lung fibrosis patients in clinical trialResearchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung ...
Baseline DLCO 1.04 (0.99-1.1);p=0.1 1.04 (1.01-1.08); p=0.011 DLCO ≥15% decrease 7.5 (1.7-33);p=0.009 7.6 (1.8-31.6); p=0.006 PLD1 (0, 1-50%, ≥50%) 0.17 (0.05-0.55); p=0.003 0.93 (0.47-1.86); p=0.8 ...
Even a 2% decline in lung function predicted poor outcomes for patients with idiopathic pulmonary fibrosis (IPF) in a new ...
Electronic nose technology was able to distinguish between multiple interstitial lung disease types with good accuracy.
Clinical efficacy endpoints included forced vital capacity of lung (FVC and %pFVC), diffusing capacity of lung for carbon monoxide (DLco), the 6-minute walk test (6MWT) and patient reported St ...
THE government has acquired a 6bn/- aircraft designed to combat crop and plant pests through aerial surveillance and ...
Of 646 SSc patients screened, 158 did not meet the eligibility criteria (mostly due to DLCO values ≥60% of predicted). Of the 488 patients enrolled, 466 underwent RHC which revealed PH in 31% of ...
Patient data such as RHC values, spirometry, 6MWD, diffusing capacity of the lungs for carbon monoxide (DLCO), and brain natriuretic peptide (BNP) at pulmonary hypertension diagnosis were obtained, as ...
Higher baseline skin score, older age, and a decline in the forced vital capacity (FVC) and the diffusing capacity for carbon monoxide (DLCO) over 2 years were independently associated with an ...
24 Pulmonary function test parameters (total lung capacity (TLC) and diffusing capacity for carbon monoxide (DLCO). Measure of quality of life with the EuroQL-5D-5L questionnaire.25 Measure of symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results